logo

Gilead Sciences Inc. (GILD)



Trade GILD now with
  Date
  Headline
8/6/2019 8:04:36 AM Gilead Canada: Ontario Provides Access To Biktarvy For Treatment Of HIV
7/30/2019 4:04:22 PM Gilead Sciences Q2 EPS $1.47 Vs. $1.39 Year Ago
7/23/2019 4:14:45 PM Gilead Presents Results From Two Studies Of Investigational TLR7 Agonists
7/23/2019 11:15:40 AM Gilead Presents Findings On Profile Of Descovy For Potential Use As HIV Pre-exposure Prophylaxis Compared With Truvada
7/19/2019 8:35:35 AM Gilead Sciences Licenses Three Preclinical Antiviral Programs From Novartis
7/17/2019 8:39:14 AM Chief Scientific Officer John McHutchison To Leave Gilead Sciences
7/17/2019 8:37:11 AM Gregg Alton And Katie Watson To Be Departing Gilead
7/17/2019 6:42:46 AM FDA Eliminates REMS For Truvada
7/11/2019 4:39:28 PM Gilead Appoints Christi Shaw As CEO Of Kite
7/11/2019 8:37:27 AM Gilead Sciences, Renown Institute For Health Innovation Announce Collaboration
7/9/2019 12:09:31 AM Lyndra Therapeutics, Gilead Sciences To Collaborate On Development Of Ultra-Long-Acting HIV Therapeutics
7/2/2019 1:23:35 AM Gilead Sciences Says Path Forward Established To Submit Filgotinib NDA In 2019
6/19/2019 8:34:18 AM Gilead And Nurix Establish Strategic Collaboration To Develop Novel Therapies For Cancer And Other Diseases